Aetna Announces Progress on Industry Leading Efforts to Simplify Prior Authorization
Rhea-AI Summary
Aetna (NYSE: CVS) announced progress simplifying prior authorization to speed access to care. Key metrics: 88% of prior authorization volume standardized, 95%+ of eligible requests approved within 24 hours, 83% processed in real time, and over 1 million provider calls eliminated.
The company also launched bundled, condition-specific prior authorization programs and integrated medical and pharmacy decisions into single reviews to streamline approvals for patients and providers.
AI-generated analysis. Not financial advice.
Positive
- 88% of prior authorization volume standardized
- 95%+ of eligible prior authorizations approved within 24 hours
- 83% processed in real time, exceeding AHIP's 80% commitment
- More than 1 million provider calls eliminated via automation
- First national payer to integrate medical and pharmacy decisions
- Launched bundled prior authorization programs including musculoskeletal and cancer bundles
Negative
- None.
News Market Reaction – CVS
On the day this news was published, CVS declined 1.17%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
CVS gained 3.18% while key health plan peers showed mixed moves: ELV (+5.14%), MOH (+6.03%), CI (+1.24%), CNC (+3.88%), HUM (-1.61%). Momentum scanner flagged HCA and CNC both moving down, indicating CVS’s advance diverged from the downside skew in scanned peers.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 08 | Provider survey update | Positive | +0.7% | Aetna survey showed optimism and strong prior authorization processing metrics. |
| Apr 06 | Earnings call notice | Neutral | -0.3% | Announcement of schedule for Q1 2026 earnings conference call and webcast. |
| Apr 01 | Omnicare sale process | Neutral | +0.9% | Omnicare entered asset purchase agreement and outlined court‑supervised sale timeline. |
| Mar 30 | Store expansion | Positive | +0.1% | Opening first pharmacy‑only Chicago location within a broader expansion plan. |
| Mar 18 | Dividend declaration | Positive | -1.6% | Declared quarterly dividend of $0.665 per share with specified record and pay dates. |
Recent CVS headlines generally saw small, aligned price reactions, with only the dividend announcement followed by a negative move.
Over the past six weeks, CVS reported several strategic and operational updates, including an Aetna provider survey, Omnicare’s court‑supervised sale process, and expansion of pharmacy‑only locations. It also declared a quarterly dividend of $0.665 per share payable on May 4, 2026. These events produced modest single‑day moves, suggesting that operational and capital return news has recently translated into incremental, not outsized, price reactions.
Market Pulse Summary
This announcement highlights Aetna’s progress in simplifying prior authorization, with 88% of volume standardized, 95%+ of eligible requests approved within 24 hours, and 83% processed in real time. It builds on earlier efforts that eliminated over 1 million provider calls through automation. In context of CVS’s recent news flow, it reinforces a theme of operational efficiency and care access, while future updates on adoption and provider response remain key metrics to monitor.
Key Terms
prior authorization medical
bundled prior authorization programs technical
musculoskeletal medical
AI-generated analysis. Not financial advice.
HARTFORD, Conn., April 24, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), is setting the pace for prior authorization reform, moving faster and further to simplify access to care for patients and providers.
Aetna today announced the company has already standardized
"Aetna is proud to lead, and most importantly, to deliver better, faster care to people who need it," said Aetna President Steve Nelson. "Prior authorization should enable care, not delay it. We're modernizing the process with speed, transparency, and clinical judgment to benefit everyone we serve."
Aetna's industry-leading results reflect its continued momentum:
95% + of eligible prior authorizations approved within 24 hours83% processed in real time, exceeding AHIP's 2027 industry commitment of80% - More than 1 million provider calls eliminated through automation and digital tools
Beyond simplification, Aetna is redefining prior authorization by becoming the first national payer to integrate medical and pharmacy decisions into single, condition-specific reviews. Newly launched bundled prior authorization programs, including a comprehensive musculoskeletal offering, build on earlier cancer bundles and create a more seamless experience for patients and providers alike.
About Aetna
Aetna, a CVS Health business, serves an estimated 37 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care professionals, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit Aetna.com (e.g., clinical diagnoses, eligibility criteria, participation in a disease state management program).
About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media Contact
David Whitrap
David.Whitrap@CVSHealth.com
857-523-1219
View original content to download multimedia:https://www.prnewswire.com/news-releases/aetna-announces-progress-on-industry-leading-efforts-to-simplify-prior-authorization-302752426.html
SOURCE CVS Health